Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancer-Reference-Cited by-同舟云学术

Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancer

Published:2021-10-05 Issue: Volume: Page:
ISSN:1435-2443
Container-title:Langenbeck's Archives of Surgery
language:en
Short-container-title:Langenbecks Arch Surg

Author:

Okada Kenjiro,Uemura Kenichiro^ORCID,Kondo Naru,Sumiyoshi Tatsuaki,Seo Shingo,Otsuka Hiroyuki,Serikawa Masahiro,Ishii Yasutaka,Tsuboi Tomofumi,Murakami Yoshiaki,Takahashi Shinya

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00423-021-02339-x.pdf

Reference35 articles.

1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30

2. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913–2921

3. Hackert T, Ulrich A, Buchler MW (2017) Can neoadjuvant therapy in pancreatic cancer increase the pool of patients eligible for pancreaticoduodenectomy? Adv Surg 51(1):1–10

4. Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH et al (2020) Prognosis based definition of resectability in pancreatic cancer: a road map to new guidelines. Ann Surg

5. Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS et al (2019) Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Surgery 166(3):277–285

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computed tomography-based vascular burden index as a predictor of vascular resection and pathological vascular invasion in pancreatic cancer with neo-adjuvant chemotherapy;European Journal of Surgical Oncology;2024-09

2. Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?;BMC Surgery;2023-09-30

3. A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma;BMC Cancer;2023-08-23

4. Surgical resection for liver recurrence after curative resection of pancreatic ductal adenocarcinoma;Langenbeck's Archives of Surgery;2023-07-17

5. Pathologic Tumor Regression is Associated With Improved Survival in Pancreatic Cancer;The American Surgeon™;2023-05-25